Cytokine signature in chronic hepatitis C patients treated with peginterferon alpha 2A and ribavirin

被引：0
|
作者：
Neuman, M. G. [1 ,2 ,3 ]
Malkiewicz, I. M. [1 ]
Esguerra, R. [1 ,2 ,3 ]
Sha, K. [1 ,2 ,3 ,5 ]
Mazulli, T. [4 ,5 ]
Moussa, G. [4 ]
Morgan, M. [6 ,7 ]
Cohen, L. [6 ]
机构：
[1] MaRS, In Vitro Drug Safety & BioTechnol, Toronto, ON, Canada
[2] Univ Toronto, Dept Pharmacol, Toronto, ON, Canada
[3] Univ Toronto, Inst Drug Res, Toronto, ON, Canada
[4] Mt Sinai Hosp, Dept Virol & Microbiol, Toronto, ON, Canada
[5] Univ Toronto, Dept Lab Med, Toronto, ON, Canada
[6] Sunnybrook Hlth Sci Ctr, Div Gastroenterol, Toronto, ON, Canada
[7] Univ Toronto, Dept Med, Toronto, ON, Canada
来源：
CLINICAL BIOCHEMISTRY | 2008年 / 41卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：198 / 198
页数：1
相关论文
共 50 条
  • [31] Randomized Study of Peginterferon-α2a Plus Ribavirin vs Peginterferon-α2b Plus Ribavirin in Chronic Hepatitis C
    Rumi, Maria Grazia
    Aghemo, Alessio
    Prati, Gian Maria
    D'Ambrosio, Roberta
    Donato, Maria Francesca
    Soffredini, Roberta
    Del Ninno, Ersilio
    Russo, Antonio
    Colombo, Massimo
    GASTROENTEROLOGY, 2010, 138 (01) : 108 - 115
  • [32] Early virologic response after peginterferon alpha-2a plus ribavirin or peginterferon alpha-2b plus ribavirin treatment in patients with chronic hepatitis C
    Di Bisceglie, A. M.
    Ghalib, R. H.
    Hamzeh, F. M.
    Rustgi, V. K.
    JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) : 721 - 729
  • [33] Toward individualized therapy with peginterferon alpha/ribavirin for chronic hepatitis C
    Dai, Chia-Yen
    ADVANCES IN DIGESTIVE MEDICINE, 2015, 2 (01) : 3 - 5
  • [34] COST-UTILITY ANALYSIS OF TELAPREVIR IN COMBINATION WITH PEGINTERFERON ALPHA AND RIBAVIRIN IN PREVIOUSLY TREATED PATIENTS WITH CHRONIC HEPATITIS C
    Lukac, M.
    Bielik, J.
    Holoman, J.
    Tomek, D.
    Suvadova, A.
    Foltanova, T.
    Foltan, V
    VALUE IN HEALTH, 2012, 15 (07) : A330 - A330
  • [35] Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: A phase II study
    Gramenzi, Annagiulia
    Cursaro, Carmela
    Margotti, Marzia
    Balsano, Clara
    Spaziani, Alessandra
    Anticoli, Simona
    Loggi, Elisabetta
    Salerno, Maddalena
    Galli, Silvia
    Furlini, Giuliano
    Bernardi, Mauro
    Andreone, Pietro
    WORLD JOURNAL OF GASTROENTEROLOGY, 2009, 15 (47) : 5946 - 5952
  • [36] Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C
    Javier García-Samaniego
    Miriam Romero
    Rafael Granados
    Remedios Alemán
    Miguel Jorge Juan
    Dolores Suárez
    Ramón Pérez
    Gregorio Castellano
    Carlos González-Portela
    World Journal of Gastroenterology, 2013, (12) : 1943 - 1952
  • [37] Factors associated with early virological response to peginterferon-α-2a/ribavirin in chronic hepatitis C
    Garcia-Samaniego, Javier
    Romero, Miriam
    Granados, Rafael
    Aleman, Remedios
    Jorge Juan, Miguel
    Suarez, Dolores
    Perez, Ramon
    Castellano, Gregorio
    Gonzalez-Portela, Carlos
    WORLD JOURNAL OF GASTROENTEROLOGY, 2013, 19 (12) : 1943 - 1952
  • [38] The value of peginterferon α-2a therapy for chronic C hepatitis in hemodialysed patients
    Ionita-Radu, F.
    Nuta, P.
    Fanea, E.
    Petrescu, L.
    Klein, C.
    Popescu, D.
    Nicolescu, I.
    Nicolaie, T.
    Rotaru, A.
    Lonescu, R.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S207 - S208
  • [39] Early hepatitis C virus changes and sustained response in patients with chronic hepatitis C treated with peginterferon α-2b and ribavirin
    Gallegos-Orozco, JF
    Loaeza-del Castillo, A
    Fuentes, AP
    García-Sandoval, M
    Soto, L
    Rodríguez, R
    Gutiérrez-Ruíz, MC
    Gutiérrez-Reyes, G
    Bonder, A
    Olivera, MA
    Kershenobich, D
    LIVER INTERNATIONAL, 2005, 25 (01) : 91 - 95
  • [40] Monitoring cytokines in chronic hepatitis C patients treated with PegInterferon alpha 2 b monotherapy
    Neuman, M. G.
    Katz, G. G.
    THERAPEUTIC DRUG MONITORING, 2007, 29 (04) : 489 - 489
12345